Clinical Characteristics of Asymptomatic Thromboembolism in Psychiatric Inpatients: A Retrospective Study

References

• Delluc A, Tromeur C, Le Ven F, et al. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France. Thromb Haemost. 2016;116:967–974. doi:10.1160/TH16-03-0205
   PubMed Web of Science ®Google Scholar
• Konstantinides SV. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(45):3145–3146. doi:10.1093/eurheartj/ehu393
   PubMed Web of Science ®Google Scholar
• Rosengren A, Freden M, Hansson P-O, et al. Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost. 2008;6(4):936–941. doi:10.4088/JCP.10m06244gry
   Web of Science ®Google Scholar
• Enga KF, Braekkan SK, Hansen-Krone IJ, et al. Emotional states and future risk of venous thromboembolism: the Tromso Study. Thromb Haemost. 2012;107:485–493. doi:10.1160/TH11-09-0667
   PubMed Web of Science ®Google Scholar
• Maly R, Masopust J, Hosak L, et al. Assessment of risk of venous thromboembolism and its possible prevention in psychiatric patients. Psychiatry Clin Neurosci. 2008;62(1):3–8. doi:10.1111/j.1440-1819.2007.01773.x
   PubMed Web of Science ®Google Scholar
• Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry. 2016;3(2):171–178. doi:10.1016/s2215-0366(15)00505-2
   PubMed Web of Science ®Google Scholar
• Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol. 2020. doi:10.1038/s41569-020-00463-7
   PubMed Web of Science ®Google Scholar
• Goldstein BI, Korczak DJ. Links between child and adolescent psychiatric disorders and cardiovascular risk. Can J Cardiol. 2020;36(9):1394–1405. doi:10.1016/j.cjca.2020.06.023
   PubMed Web of Science ®Google Scholar
• Latvala A, Kuja-Halkola R, Ruck C, et al. Association of resting heart rate and blood pressure in late adolescence with subsequent mental disorders: a Longitudinal Population Study of More Than 1 Million Men in Sweden. JAMA Psychiatry. 2016;73(12):1268–1275. doi:10.1001/jamapsychiatry.2016.2717
   PubMed Web of Science ®Google Scholar
• Manu P, Kane JM, Correll CU. Sudden deaths in psychiatric patients. J Clin Psychiatry. 2011;72(07):936–941. doi:10.4088/JCP.10m06244gry
   PubMedGoogle Scholar
• Ishida T, Katagiri T, Uchida H, et al. Incidence of deep vein thrombosis in restrained psychiatric patients. Psychosomatics. 2014;55(1):69–75. doi:10.1016/j.psym.2013.04.001
   PubMed Web of Science ®Google Scholar
• Masopust J, Bazantova V, Kuca K, et al. Venous thromboembolism as an adverse effect during treatment with olanzapine: a case series. Front Psychiatry. 2019;10:330. doi:10.3389/fpsyt.2019.00330
   PubMed Web of Science ®Google Scholar
• Wilbur J, Shian B. Deep venous thrombosis and pulmonary embolism: current therapy. Am Fam Physician. 2017;95:295–302.
   PubMed Web of Science ®Google Scholar
• Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349(13):1227–1235. doi:10.1056/NEJMoa023153
   PubMed Web of Science ®Google Scholar
• Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144:165–171. doi:10.7326/0003-4819-144-3-200602070-00004
   PubMed Web of Science ®Google Scholar
• Karny-Epstein N, Abuhasira R, Grossman A. Current use of D-dimer for the exclusion of venous thrombosis in hospitalized patients. Sci Rep. 2022;12:12376. doi:10.1038/s41598-022-16515-6
   PubMed Web of Science ®Google Scholar
• Lin CE, Chung CH, Chen LF, et al. Increased risk for venous thromboembolism among patients with concurrent depressive, bipolar, and schizophrenic disorders. Gen Hosp Psychiatry. 2019;61:34–40. doi:10.1016/j.genhosppsych.2019.10.003
   PubMed Web of Science ®Google Scholar
• von Kanel R, Margani A, Stauber S, et al. Depressive symptoms as a novel risk factor for recurrent venous thromboembolism: a longitudinal observational study in patients referred for thrombophilia investigation. PLoS One. 2015;10:e0125858. doi:10.1371/journal.pone.0125858
   PubMed Web of Science ®Google Scholar
• Takeshima M, Ishikawa H, Shimizu K, et al. Incidence of venous thromboembolism in psychiatric inpatients: a chart review. Neuropsychiatr Dis Treat. 2018;14:1363–1370. doi:10.2147/NDT.S162760
   PubMed Web of Science ®Google Scholar
• Crawford F, Andras A, Welch K, et al. D-dimer test for excluding the diagnosis of pulmonary embolism. Cochrane Database Syst Rev. 2016;2016(8):CD010864. doi:10.1002/14651858.CD010864.pub2
   PubMedGoogle Scholar
• Johansson M, Johansson L, Wennberg P, et al. Physical activity and risk of first-time venous thromboembolism. Eur J Prev Cardiol. 2019;26(11):1181–1187. doi:10.1177/2047487319829310
   PubMed Web of Science ®Google Scholar
• Rinde FB, Jorgensen CT, Pettersen HH, et al. Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry. J Thromb Haemost. 2023;21(7):1861–1868. doi:10.1016/j.jtha.2023.03.026
   PubMed Web of Science ®Google Scholar
• Poudel A, Poudel Y, Adhikari A, et al. D-dimer as a biomarker for assessment of COVID-19 prognosis: d-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS One. 2021;16(8):e0256744. doi:10.1371/journal.pone.0256744
   PubMed Web of Science ®Google Scholar
• Parkin L, Balkwill A, Sweetland S, et al. Antidepressants, depression, and venous thromboembolism risk: large Prospective Study of UK Women. J Am Heart Assoc. 2017;6:e005316. doi:10.1161/JAHA.116.005316
   PubMed Web of Science ®Google Scholar
• Jonsson AK, Schill J, Olsson H, et al. Venous thromboembolism during treatment with antipsychotics: a review of current evidence. CNS Drugs. 2018;32(1):47–64. doi:10.1007/s40263-018-0495-7
   PubMed Web of Science ®Google Scholar
• Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet. 2000;356(9237):1219–1223. doi:10.1016/S0140-6736(00)02784-7
   PubMed Web of Science ®Google Scholar
• Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341(sep21 1):c4245. doi:10.1136/bmj.c4245
   PubMedGoogle Scholar
• Shen Q, Mikkelsen DH, Luitva LB, et al. Psychiatric disorders and subsequent risk of cardiovascular disease: a longitudinal matched cohort study across three countries. EClinicalMedicine. 2023;61:102063. doi:10.1016/j.eclinm.2023.102063
   PubMedGoogle Scholar
• Di X, Chen M, Shen S, et al. Antipsychotic use and risk of venous thromboembolism: a meta-analysis. Psychiatry Res. 2021;296:113691. doi:10.1016/j.psychres.2020.113691
   PubMed Web of Science ®Google Scholar
• Jonsson AK, Spigset O, Hagg S. Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management. CNS Drugs. 2012;26(8):649–662. doi:10.2165/11633920-000000000-00000
   PubMed Web of Science ®Google Scholar